<unk>  is sometimes described as a slowly progressive disorder with long asymptomatic periods punctuated by thrombotic or hemorrhagic events. However, well-documented medical regimens can reduce and control the number of platelets, which reduces the risk of these thrombotic or hemorrhagic events. The lifespan of a well-controlled<unk>  person is well within the expected range for a person of similar age but without<unk> .<unk>  is the myeloproliferative neoplasm least likely to progress to acute myeloid leukemia.
Essential thrombocythemia
Refractory cytopenia of childhood
Polycythemia vera
Transient erythroblastopenia of childhood
Primary myelofibrosis
Chronic neutrophilic leukemia
Drug-induced thrombocytopenic purpura
Aplastic anemia